Cite

HARVARD Citation

    Luo, L. et al. (2021). Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma. Journal of immunology research. p. . [Online]. 
  
Back to record